Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Pabst

Showing results (61-70 of 332) with videos related to

Pageof 34
Sort By:
Hematological Oncology|June 5, 2018
Adverse outcome of AML with aberrant CD16 and CD56 NK cell marker expressionAlexandra Junge, Ulrike Bacher, Beatrice U Mueller, et al.
Current Issues in Molecular Biology|August 28, 2024
Rising Prevalence of Low-Frequency <i>PPM1D</i> Gene Mutations after Second HDCT in Multiple MyelomaKatja Seipel, Nuria Z Veglio, Henning Nilius, et al.
Current Issues in Molecular Biology|June 20, 2022
sBCMA Plasma Level Dynamics and Anti-BCMA CAR-T-Cell Treatment in Relapsed Multiple MyelomaKatja Seipel, Naomi Porret, Gertrud Wiedemann, et al.
Transfusion|August 29, 2006
Progenitor cell recruitment during individualized high-flow, very-large-volume apheresis for autologous transplantation improves collection efficiencyStefano Fontana, Rachel Groebli, Kurt Leibundgut, et al.
Hemasphere|November 15, 2019
Hematopoietic Stem Cell Mobilization With Plerixafor Is Safe and Effective in Poorly Mobilizing Acute Myeloid Leukemia PatientsEvgenyi Shumilov, Urban Novak, Barbara Jeker, et al.
Haematologica|July 7, 2018
MDM2- and FLT3-inhibitors in the treatment of <i>FLT3</i>-ITD acute myeloid leukemia, specificity and efficacy of NVP-HDM201 and midostaurinKatja Seipel, Miguel A T Marques, Corinne Sidler, et al.
Journal of Cellular and Molecular Medicine|August 8, 2009
Unfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemiaJulian A Schardt, Marianne Eyholzer, Nikolai A Timchenko, et al.
Cancers|July 2, 2021
Clonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AMLAlexander D Heini, Naomi Porret, Reinhard Zenhaeusern, et al.
International Journal of Molecular Sciences|October 29, 2025
Clinical Impact of LAG3 Single-Nucleotide Polymorphism in DLBCL Treated with CAR-T Cell TherapyKatja Seipel, Sophia Maria Spahr, Inna Shaforostova, et al.
Cancers|June 3, 2018
The Cellular p53 Inhibitor MDM2 and the Growth Factor Receptor FLT3 as Biomarkers for Treatment Responses to the MDM2-Inhibitor Idasanutlin and the MEK1 Inhibitor Cobimetinib in Acute Myeloid LeukemiaKatja Seipel, Miguel A T Marques, Corinne Sidler, et al.
Pageof 34

Showing results (61-70 of 332) with videos related to

Sort By:
Pageof 34
Hematological Oncology|June 5, 2018
Adverse outcome of AML with aberrant CD16 and CD56 NK cell marker expressionAlexandra Junge, Ulrike Bacher, Beatrice U Mueller, et al.
Current Issues in Molecular Biology|August 28, 2024
Rising Prevalence of Low-Frequency <i>PPM1D</i> Gene Mutations after Second HDCT in Multiple MyelomaKatja Seipel, Nuria Z Veglio, Henning Nilius, et al.
Current Issues in Molecular Biology|June 20, 2022
sBCMA Plasma Level Dynamics and Anti-BCMA CAR-T-Cell Treatment in Relapsed Multiple MyelomaKatja Seipel, Naomi Porret, Gertrud Wiedemann, et al.
Transfusion|August 29, 2006
Progenitor cell recruitment during individualized high-flow, very-large-volume apheresis for autologous transplantation improves collection efficiencyStefano Fontana, Rachel Groebli, Kurt Leibundgut, et al.
Hemasphere|November 15, 2019
Hematopoietic Stem Cell Mobilization With Plerixafor Is Safe and Effective in Poorly Mobilizing Acute Myeloid Leukemia PatientsEvgenyi Shumilov, Urban Novak, Barbara Jeker, et al.
Haematologica|July 7, 2018
MDM2- and FLT3-inhibitors in the treatment of <i>FLT3</i>-ITD acute myeloid leukemia, specificity and efficacy of NVP-HDM201 and midostaurinKatja Seipel, Miguel A T Marques, Corinne Sidler, et al.
Journal of Cellular and Molecular Medicine|August 8, 2009
Unfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemiaJulian A Schardt, Marianne Eyholzer, Nikolai A Timchenko, et al.
Cancers|July 2, 2021
Clonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AMLAlexander D Heini, Naomi Porret, Reinhard Zenhaeusern, et al.
International Journal of Molecular Sciences|October 29, 2025
Clinical Impact of LAG3 Single-Nucleotide Polymorphism in DLBCL Treated with CAR-T Cell TherapyKatja Seipel, Sophia Maria Spahr, Inna Shaforostova, et al.
Cancers|June 3, 2018
The Cellular p53 Inhibitor MDM2 and the Growth Factor Receptor FLT3 as Biomarkers for Treatment Responses to the MDM2-Inhibitor Idasanutlin and the MEK1 Inhibitor Cobimetinib in Acute Myeloid LeukemiaKatja Seipel, Miguel A T Marques, Corinne Sidler, et al.
Pageof 34